Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting-A Single Center Experience.

Kinga Czarnecka Paulina CzarneckaOlga TroninaMagdalena Durlik

Published in: Journal of clinical medicine (2022)

Molnupiravir may be perceived as an alternative treatment for patients with immunosuppression and advanced chronic kidney disease. Nevertheless, further studies are required to conclusively establish a role for molnupiravir in future COVID-19 treatment recommendations.

Keyphrases

chronic kidney disease
coronavirus disease
sars cov
depressive symptoms
physical activity
combination therapy
social support
end stage renal disease
clinical practice
replacement therapy
current status
smoking cessation